Trials / Withdrawn

WithdrawnNCT01215058

Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer

Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal Bleeding Ulcer or a Symptomatic Ulcer With Non-steroidal Anti-inflammatory Drug (NSAID) in France

Status: Withdrawn
Phase: —
Study type: Observational
Enrollment: 0 (actual)

Sponsor: AstraZeneca · Industry
Sex: All
Age: —
Healthy volunteers: Accepted

Summary

The purpose of this study is to assess gastroprotective agent compliance in patients at risk suffering from a gastrointestinal bleeding ulcer or a symptomatic ulcer with NSAID.

Conditions

Gastrointestinal Hemorrhage
Ulcer

Timeline

Start date: 2010-10-01
Primary completion: 2011-04-01
Completion: 2011-04-01
First posted: 2010-10-05
Last updated: 2010-10-22

Source: ClinicalTrials.gov record NCT01215058. Inclusion in this directory is not an endorsement.